Terminal
Stocks
Spotlight
Research

Stocks
Healthcare
NASDAQ
TLX

Market Cap: $3.82B

TL

Telix Pharmaceuticals Limited

TLX

NASDAQUSD

Overview News Analyst Reports Financials Politician Trades Insider Trades Executive Patents Earnings Surprise

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

Stocks About Advertisers Brokers Contact

Legal

Terms of Service Privacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability

Gross Profit Margin52.16%

EBITDA Margin3.45%

EBIT Margin-0.73%

Pre-tax Margin3.13%

Net Profit Margin3.60%

Earnings Yield0.89%

Valuation Multiples

Price / Book7.55

Price / Sales4.05

Price / Earnings113.39

PEG-0.40

Forward PEG-2.34

EV / Sales4.41

EV / EBITDA127.97

EV / Operating Cash Flow-267.94

EV / Free Cash Flow-65.18

Price / Free Cash Flow-59.84

Price / Operating Cash Flow-246.32

Cash Flow & Capital

Free Cash Flow / Share-$0.26

Operating Cash Flow / Share-$0.06

Free Cash Flow Yield-1.67%

Capex / Revenue5.12%

Capex / Operating Cash Flow-3.11%

Capex / Depreciation1.23

Stock Compensation / Revenue0.00%

Dividend Payout Ratio0.00%

Dividend Yield0.00%

Liquidity & Leverage

Current Ratio2.01

Quick Ratio1.85

Cash Ratio1.04

Debt / Assets0.43

Debt / Capital0.54

Debt / Equity1.19

Long-Term Debt / Capital0.51

Debt / Market Cap14.15%

Net Debt / EBITDA10.48

Solvency Ratio0.08

Financial Leverage2.79

Efficiency & Working Capital

Asset Turnover0.67

Fixed Asset Turnover7.00

Inventory Turnover11.13

Receivables Turnover5.33

Payables Turnover2.57

Days Sales Outstanding68.5

Days Inventory Outstanding32.8

Days Payables Outstanding141.99

Operating Cycle101.3

Cash Conversion Cycle-40.69

Working Capital Turnover5.21

Returns & Quality

Return on Equity7.11%

Return on Assets2.40%

Return on Invested Capital-0.58%

ROCE-0.59%

Return on Tangible Assets4.21%

Operating Return on Assets-0.51%

Income Quality-0.46

Tax Burden1.15

Interest Burden-4.28

Balance Sheet & Intrinsic Metrics

Enterprise Value$5.78B

Invested Capital$1.39B

Working Capital$354.61M

Tangible Asset Value$-139.92M

Net Current Asset Value$-557.38M

Graham Number$2.55

Graham Net-Net-$2.02

Book Value / Share$2.08

Tangible Book Value / Share-$0.41

Cash / Share$1.07

Financial Health Scores

Piotroski Score4

Altman Z-Score4.02

Revenue$2.5B

EBIT$67.82M

Market Cap$5.33B

Working Capital$354.63M

Retained Earnings$-160.08M

Total Assets$1.97B

Total Liabilities$1.26B